Current Value
$17.821 Year Return
Current Value
$17.821 Year Return
Double maintains 1 strategies that include PLSE - Pulse Biosciences, Inc.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IBD | 0.09% | $381.25M | 0.43% |
XONE | 0.11% | $616.52M | 0.03% |
XBIL | -0.17% | $779.01M | 0.15% |
SHYM | -0.19% | $323.12M | 0.35% |
FTXG | -0.25% | $28.41M | 0.6% |
IBMN | 0.27% | $449.34M | 0.18% |
TFLO | 0.44% | $7.03B | 0.15% |
SGOV | 0.44% | $47.13B | 0.09% |
ASHR | 0.61% | $2.02B | 0.65% |
STPZ | 0.63% | $453.91M | 0.2% |
KCCA | 0.69% | $94.38M | 0.87% |
CNYA | 0.83% | $218.02M | 0.6% |
UTWO | 0.83% | $380.80M | 0.15% |
KRBN | 0.83% | $158.46M | 0.85% |
CARY | -0.88% | $347.36M | 0.8% |
IBMO | -0.93% | $517.17M | 0.18% |
KBA | 1.09% | $173.36M | 0.56% |
SHYD | -1.11% | $321.41M | 0.35% |
TBIL | 1.16% | $5.85B | 0.15% |
PWZ | -1.25% | $673.45M | 0.28% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CERS | 39.86% | $235.13M | -32.79% | 0.00% |
IDYA | 37.76% | $1.76B | -43.98% | 0.00% |
DIOD | 35.13% | $2.12B | -37.41% | 0.00% |
RMBS | 34.40% | $5.86B | -1.09% | 0.00% |
PLUS | 34.02% | $1.89B | -3.84% | 0.00% |
VSH | 33.14% | $1.94B | -38.93% | 2.83% |
IMMR | 33.05% | $246.54M | -21.84% | 1.79% |
KN | 32.88% | $1.44B | -5.53% | 0.00% |
SXI | 32.72% | $1.86B | -7.04% | 0.82% |
GHM | 32.66% | $428.48M | +45.34% | 0.00% |
BDC | 32.43% | $4.25B | +12.70% | 0.19% |
DNLI | 32.35% | $1.97B | -26.65% | 0.00% |
AVXL | 31.97% | $651.39M | +84.30% | 0.00% |
RLGT | 31.72% | $282.86M | +14.29% | 0.00% |
CDZI | 31.56% | $242.35M | -2.31% | 0.00% |
CBL | 31.52% | $776.80M | +18.27% | 6.40% |
NXRT | 31.39% | $866.25M | -4.33% | 5.75% |
NUVL | 31.35% | $5.37B | +12.45% | 0.00% |
PJT | 31.34% | $3.69B | +41.50% | 0.66% |
GLW | 31.32% | $42.79B | +35.17% | 2.27% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -30.77% | $320.45M | 1.43% |
VIXY | -24.00% | $141.70M | 0.85% |
TAIL | -19.94% | $111.21M | 0.59% |
TBLL | -10.15% | $2.32B | 0.08% |
IVOL | -9.18% | $348.07M | 1.02% |
CTA | -9.15% | $1.08B | 0.76% |
WEAT | -8.69% | $118.99M | 0.28% |
ULST | -7.51% | $660.43M | 0.2% |
USDU | -6.63% | $169.24M | 0.5% |
UUP | -6.56% | $267.96M | 0.77% |
BILS | -4.97% | $3.94B | 0.1356% |
TPMN | -3.69% | $30.91M | 0.65% |
BIL | -3.19% | $44.37B | 0.1356% |
CORN | -3.16% | $49.71M | 0.2% |
JMST | -3.06% | $3.76B | 0.18% |
XHLF | -3.02% | $1.48B | 0.03% |
IYK | -2.81% | $1.53B | 0.4% |
CLIP | -2.48% | $1.50B | 0.07% |
FTSD | -1.70% | $212.84M | 0.25% |
AGZD | -1.33% | $106.82M | 0.23% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IWC | 39.15% | $784.70M | 0.6% |
CPRJ | 38.23% | $47.63M | 0.69% |
IWO | 38.06% | $11.24B | 0.24% |
IWM | 37.11% | $63.57B | 0.19% |
VTWO | 36.95% | $12.05B | 0.07% |
KJAN | 36.56% | $300.25M | 0.79% |
ITEQ | 36.54% | $89.42M | 0.75% |
GSSC | 36.48% | $532.99M | 0.2% |
ISCG | 36.13% | $658.37M | 0.06% |
SCHA | 35.88% | $16.81B | 0.04% |
SLYG | 35.87% | $3.29B | 0.15% |
KOMP | 35.77% | $2.18B | 0.2% |
VBK | 35.68% | $18.20B | 0.07% |
ESPO | 35.55% | $355.52M | 0.56% |
IJT | 35.37% | $5.98B | 0.18% |
PRFZ | 35.33% | $2.32B | 0.34% |
KJUL | 35.16% | $115.62M | 0.79% |
XBI | 35.10% | $4.60B | 0.35% |
XSMO | 35.05% | $1.56B | 0.39% |
IWN | 34.94% | $10.88B | 0.24% |
Yahoo
HAYWARD, Calif., May 23, 2025--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced that the Compensation Committee of its Board of Directors has granted equity awards to four new employees as equity inducement awards outside of the Company's 2017 Equity Incentive Plan, but under the terms of the 2017 Inducement Equity Incentive Plan. The equity awards were approved and issu
Yahoo
Key Insights Pulse Biosciences' significant insider ownership suggests inherent interests in company's expansion The...
SeekingAlpha
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q1 2025 Earnings Call May 8, 2025 4:30 PM ETCompany ParticipantsPhilip Taylor - Gilmartin GroupJon Skinner â CFOPaul...
Yahoo
Pulse Biosciences Inc (PLSE) showcases technological breakthroughs and strategic growth plans despite increased losses and expenses.
Yahoo
HAYWARD, Calif., May 08, 2025--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced business updates and financial results for the first quarter ended March 31, 2025.
Yahoo
HAYWARD, Calif., May 06, 2025--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced plans to present at the upcoming BofA Securities 2025 Health Care Conference in Las Vegas.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CYD | -<0.01% | $652.82M | +104.47% | 2.19% |
ELV | <0.01% | $85.98B | -25.00% | 1.73% |
BBVA | 0.02% | $86.84B | +39.43% | 5.15% |
SITC | -0.03% | $628.81M | +8.23% | 1.09% |
VTR | 0.03% | $28.95B | +30.92% | 2.86% |
TEN | -0.04% | $536.87M | -42.53% | 8.24% |
TXO | 0.04% | $826.70M | -28.92% | 15.60% |
TEF | 0.04% | $29.80B | +15.28% | 5.95% |
NOC | -0.05% | $69.00B | +7.36% | 1.29% |
OPCH | 0.07% | $5.28B | +8.62% | 0.00% |
SUZ | 0.07% | $11.07B | -3.43% | 0.00% |
EVRI | 0.09% | $1.23B | +107.79% | 0.00% |
FYBR | -0.10% | $9.13B | +36.49% | 0.00% |
ASC | 0.10% | $389.99M | -58.26% | 10.00% |
PAC | -0.11% | $10.01B | +23.27% | 0.00% |
OMAB | -0.12% | $4.10B | +23.25% | 4.65% |
HE | -0.14% | $1.88B | +2.07% | 0.00% |
NXST | -0.15% | $5.14B | +4.34% | 4.17% |
MRK | 0.16% | $191.84B | -38.65% | 4.11% |
PPC | -0.17% | $11.62B | +54.56% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
KDP | -13.64% | $45.43B | -1.33% | 2.70% |
GIS | -11.28% | $29.56B | -18.99% | 4.45% |
CBOE | -11.19% | $23.79B | +30.06% | 1.07% |
MDLZ | -10.97% | $87.36B | -0.62% | 2.72% |
PEP | -10.27% | $180.87B | -22.62% | 4.11% |
CLX | -9.96% | $16.14B | +1.53% | 3.72% |
CHD | -9.03% | $24.17B | -5.96% | 1.18% |
KO | -8.82% | $307.71B | +15.36% | 2.74% |
BTCT | -8.43% | $22.13M | +59.26% | 0.00% |
MCK | -7.55% | $89.19B | +27.08% | 0.39% |
MOMO | -7.52% | $759.57M | +14.62% | 0.00% |
GSK | -6.98% | $81.04B | -9.13% | 3.97% |
CAH | -6.36% | $36.75B | +57.60% | 1.32% |
CL | -6.33% | $74.80B | +1.51% | 2.18% |
CAG | -6.28% | $10.82B | -22.26% | 6.19% |
HSY | -6.14% | $32.68B | -16.47% | 3.42% |
VHC | -6.11% | $33.26M | +91.41% | 0.00% |
AGL | -6.08% | $923.11M | -64.26% | 0.00% |
EDU | -5.75% | $8.02B | -40.85% | 0.00% |
CME | -5.54% | $103.02B | +39.52% | 3.67% |